The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
Open accessAbstract
Importance: The National COVID Cohort Collaborative (N3C) is a centralized, harmonized, high-granularity electronic health record repository that is the largest, most representative COVID-19 cohort to date. This multicenter data set can support robust evidence-based development of predictive and diagnostic tools and inform clinical care and policy. Objectives: To evaluate COVID-19 severity and risk factors over time and assess the use of machine learning to predict clinical severity. Design, Setting, and Participants: In a retrospective cohort study of 1 926 526 US adults with SARS-CoV-2 infection (polymerase chain reaction >99% or antigen <1%) and adult patients without SARS-CoV-2 infection who served as controls from 34 medical centers nationwide between January 1, 2020, and December 7, 2020, patients were stratified using a World Health Organization COVID-19 severity scale and demographic characteristics. Differences between groups over time were evaluated using multivariable logistic regression. Random forest and XGBoost models were used to predict severe clinical course (death, discharge to hospice, invasive ventilatory support, or extracorporeal membrane oxygenation). Main Outcomes and Measures: Patient demographic characteristics and COVID-19 severity using the World Health Organization COVID-19 severity scale and differences between groups over time using multivariable logistic regression. Results: The cohort included 174 568 adults who tested positive for SARS-CoV-2 (mean [SD] age, 44.4 [18.6] years; 53.2% female) and 1 133 848 adult controls who tested negative for SARS-CoV-2 (mean [SD] age, 49.5 [19.2] years; 57.1% female). Of the 174 568 adults with SARS-CoV-2, 32 472 (18.6%) were hospitalized, and 6565 (20.2%) of those had a severe clinical course (invasive ventilatory support, extracorporeal membrane oxygenation, death, or discharge to hospice). Of the hospitalized patients, mortality was 11.6% overall and decreased from 16.4% in March to April 2020 to 8.6% in September to October 2020 (P = .002 for monthly trend). Using 64 inputs available on the first hospital day, this study predicted a severe clinical course using random forest and XGBoost models (area under the receiver operating curve = 0.87 for both) that were stable over time. The factor most strongly associated with clinical severity was pH; this result was consistent across machine learning methods. In a separate multivariable logistic regression model built for inference, age (odds ratio [OR], 1.03 per year; 95% CI, 1.03-1.04), male sex (OR, 1.60; 95% CI, 1.51-1.69), liver disease (OR, 1.20; 95% CI, 1.08-1.34), dementia (OR, 1.26; 95% CI, 1.13-1.41), African American (OR, 1.12; 95% CI, 1.05-1.20) and Asian (OR, 1.33; 95% CI, 1.12-1.57) race, and obesity (OR, 1.36; 95% CI, 1.27-1.46) were independently associated with higher clinical severity. Conclusions and Relevance: This cohort study found that COVID-19 mortality decreased over time during 2020 and that patient demographic characteristics and comorbidities were associated with higher clinical severity. The machine learning models accurately predicted ultimate clinical severity using commonly collected clinical data from the first 24 hours of a hospital admission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mehra, M. R., Ruschitzka, F., & Patel, A. N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31324-6 · Cited by 553 · cited 1×
“7) (n = 3106) Hospital LOS, median (IQR), d NR NR 4 (2-8) (n = 25 906) 23 (12-37) (n = 2790) 9 (4-18) (n = 3775)”
RetractedThe meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674 · cited 2×
“The N3C includes patients with any encounter after January 1, 2020, with (1) 1 of a set of a priori–defined SARS-CoV-2 laboratory tests, or (2) a strong positive diagnostic code, or (3) 2 weak positive diagnostic codes during the same encounter or on the same date before May 1, 2020.”
MethodClinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Hospitalization and mortality among Black patients and White patients with Covid-19.
Price-Haywood, E. G., Burton, J., Fort, D., & Seoane, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmsa2011686 · Cited by 1,660 · cited 1×
“7) (n = 3106) Hospital LOS, median (IQR), d NR NR 4 (2-8) (n = 25 906) 23 (12-37) (n = 2790) 9 (4-18) (n = 3775)”
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
Haendel, M. A., Chute, C. G., Bennett, T. D., Eichmann, D. A., Guinney, J., Kibbe, W. A., Payne, P. R. O., Pfaff, E. R., Robinson, P. N., Saltz, J. H., et al. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa196 · Cited by 553
Self-citationTrends in COVID-19 risk-adjusted mortality rates
Horwitz, L. I., Jones, S. A., Cerfolio, R. J., Francois, F., Greco, J., Rudy, B., & Petrilli, C. M. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3552 · Cited by 229
Cited by
Human genetic and immunological determinants of critical COVID-19 pneumonia
Zhang, Q., Bastard, P., Effort, C. H. G., Karbuz, A., Gervais, A., Tayoun, A. A., Aiuti, A., Belot, A., Bolze, A., Gaudet, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04447-0 · Cited by 366
Self-citationSun, J., Zheng, Q., Madhira, V., Olex, A. L., Anzalone, A. J., Vinson, A., Singh, J. A., French, E., Abraham, A. G., Mathew, J., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.7024 · Cited by 265
Self-citationZidan, N., Dey, V., Allen, K., Price, J., Zappone, S. R., Hebert, C., Schleyer, T., & Ning, X. (2023) · JAMIA Open · doi:10.1093/jamiaopen/ooad002 · Cited by 11
Jacobson, E., Troost, J. P., Epler, K., Lenhan, B., Rodgers, L., O'Callaghan, T., Painter, N., & Barrett, J. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2022.0578 · Cited by 4
“26,27 One would speculate that doctors caring for individuals with COVID-19 and obesity would be aware of the risk for severe disease and clinical decline and may thus recommend less—not more—aggressive resuscitation.”
Metadata
- Authors
- Bennett, T. D., Moffitt, R. A., Hajagos, J. G., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., DeWitt, P. E., Gabriel, D., Garibaldi, B. T., Girvin, A. T., Guinney, J., Hill, E. L., Hong, S. S., Jimenez, H., Kavuluru, R., Kostka, K., Lehmann, H. P., Levitt, E., Mallipattu, S. K., Manna, A., McMurry, J. A., Morris, M., Muschelli, J., Neumann, A. J., Palchuk, M. B., Pfaff, E. R., Qian, Z., Qureshi, N., Russell, S., Spratt, H., Walden, A., Williams, A. E., Wooldridge, J. T., Yoo, Y. J., Zhang, X. T., Zhu, R. L., Austin, C. P., Saltz, J. H., Gersing, K. R., Haendel, M. A., Chute, C. G., National COVID Cohort Collaborative (N3C) Consortium, Gagnier, J., Hu, S., Lota, K., Maidlow, S., Hanauer, D. A., Weatherwax, K., Gandrakota, N., Kamaleswaran, R., Martin, G., Qian, J., Farley, J. E., Francis, P. A., Jiao, D., Kharrazi, H., Reese, J. T., Deacy, M., Sheikh, U., Chen, J., Patton, M., Ramsey, T., Singh, J., Cimino, J. J., Su, J., Adams, W. G., Duong, T., Buse, J. B., Islam, J. Y., Obeid, J. S., Meystre, S., Patterson, S., Zemmel, M., Grider, R., Martinez, A., Santos, C., Solway, J., Chiu, R., Brown, G. B., Cui, J., Liang, S., Khanipov, K., Harper, J. R., Embi, P. J., Eichmann, D. A., Knosp, B. M., Hillegass, W., Wu, C., Aaron, J., Henderson, D., Gul, M., Harper, T., Harris, D., Talbert, J., Bahroos, N., Dubinett, S., Mathew, J., McMahan, G., Liu, H., Lucchinetti, C., Schwartz, D. L., Sacco, R., Taghioff, P., Harper, D., Angst, D., Marek, A., Figueroa Castro, C. E., Blazar, B., Johnson, S. G., Basford, M., Jones, L., Bernard, G., Wright, R., Finkelstein, J., Campion, T. R., Mason, C. E., Fuld, X., Anzalone, A., McClay, J. C., Visweswaran, S., Cook, C., Dest, A., Ellison, D., Relevo, R., Volz, A. M., Zhang, C., Tenzer, M., Bowers, D. S., Farrell, F., Qin, Q., Zand, M., Holden-Wiltse, J., Gouripeddi, R., Facelli, J., Clark, R., Becerra, B., Yan, Y., Phuong, J., Chae, Y., Patel, R. C., Suver, C., Zampino, E., Said, A. S., Payne, P. R. O., Jawa, R., Elkin, P. L., Koraishy, F. M., Golovko, G., Subbian, V., Weisdorf, D., Sinoway, L., Morizono, H., Crandall, K. A., Rahnavard, A., Shara, N., Taxter, A., Ostasiewski, B., Song, Q., Vangala, U. M. R., De Luzuriaga, K. R., Khatib, R., Kirwan, J., von Oehsen, J., Moore, J., Sakhuja, A., & Rutter, J.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2021-07-13
- Volume
- 4
- Issue
- 7
- Pages
- e2116901
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3179372724
- Cited by
- 231
- References
- 12
- FWCI
- 14.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. https://app.cochat.ai/papers/10.1001/jamanetworkopen.2021.16901
- The paper
- Bennett, T. D., Moffitt, R. A., Hajagos, J. G., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., DeWitt, P. E., Gabriel, D., Garibaldi, B. T., Girvin, A. T., Guinney, J., Hill, E. L., Hong, S. S., Jimenez, H., Kavuluru, R., . . . Rutter, J. (2021). Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2021.16901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.